Article Details
Retrieved on: 2018-01-13 20:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. boosted its stake in Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB) by 0.6% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 453,805 shares of the specialty pharmaceutical ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here